+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-07-01Number of Pages: 85

Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. Technological advancement in tissue engineering and stem cell therapy is expected to drive the global market for regenerative medicine (bone and joint). Moreover, growing prevalence of bone and joint disorder has also accounted for the market growth of the global regenerative medicine (bone and joint). However, factors such as stringent regulatory compliance, ethical issues pertaining to stem cell therapy and post implantation rejection are expected to hinder the global market growth during the forecast period. The global regenerative medicine (bone and joint) market was valued at USD 2,589.5 million in 2012 and is expected to grow at a CAGR of 12.8% from 2013 to 2019, to reach an estimated value of USD 6,473.4 million by 2019. 

 

The global market for regenerative medicine is segmented based on technology as stem cell therapy, biomaterials and tissue engineering. In 2012, biomaterials segment accounted for the largest market share in the global regenerative medicine (bone and joint) market owing to favorable reimbursement policies and strong demand of biomaterials in the global market. Moreover, tissue engineering is expected to grow at the highest CAGR during the forecast period. 

 

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application as bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. In 2012, bone graft substitute segment accounted for the largest market share in the global regenerative medicine bone and joint application market owing to growing demand of bone graft substitute in orthopaedic surgeries. Autogenic bone application segment is expected to grow at the highest CAGR during the forecast period 2013 to 2019.  

 

North America was the largest market for regenerative medicine bone and joint application in 2012, accounting for largest market share of the total regenerative medicine (bone and joint) market. The regenerative medicine market in North America witnessed significant growth due to increasing demand of bone and joint reconstructive surgeries. Moreover, favorable government initiatives have also supported the growth of the regenerative medicine bone and joint application market in this region. European market was the second largest of the global market in 2012. Rising geriatric population in European Union is one of the major market drivers in this region as the geriatric group is more prone to suffer from arthritis. Moreover, extensive support and funding provided by European government for regenerative medicine would further accentuate the market growth in this region. 

  

Asia-Pacific was observed to be a promising market for regenerative medicine bone and joint application during the study period owing to the demand of bone graft substitute in this region. This region is considered as an emerging market and is estimated to grow at the highest CAGR from 2013 to 2019. Manufacturer of regenerative medicine bone and joint products are expanding their operation in Asian countries (India, China, Japan and South Korea) as these economies hold immense potential for regenerative medicine bone and joint application. For instance, in May 2013, Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian medical technology company. Sushrut Surgicals product portfolio includes trauma implants and instruments, spine and limb salvage products. This acquisition would expand and enhance the product offerings of Smith & Nephew and would also assist in capturing lucrative market share in Asia-Pacific region. In terms of key players the global regenerative medicine bone and joint application market is highly fragmented that comprises of DePuy Synthes, Inc. (HEALOS Bone Graft), Medtronic, Inc. (INFUSE Bone Graft), Stryker Corporation (Vitoss Bone Graft Substitute) and Zimmer Holdings, Inc (CopiOs Bone Void Filler). 

 

 

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Market Drivers

      3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products

      3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products

      3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market

3.3 Restraints

      3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market

      3.3.2 Ethical issues and post implantation infections are hindering overall market growth

3.4 Opportunities

      3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific

3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market

      3.5.1 Bargaining power of suppliers

      3.5.2 Bargaining power of buyers

      3.5.3 Threat of new entrants

      3.5.4 Threat of substitutes

      3.5.5 Competitive rivalry

3.6 Competitive Landscape

      3.6.1 Market Share Analysis by Key Players, 2012 (Value %)

3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

 

Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology

4.1 Introduction

      4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

4.2 Stem Cell Therapy

      4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

4.3 Biomaterials

      4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

4.4 Tissue Engineering

      4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications

5.1 Overview

      5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

5.2 Bone Graft Substitutes

      5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

5.3 Osteoarticular Diseases

      5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

5.4 Allogeneic Bones

      5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

5.5 Autogenic Bones

      5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

5.6 Others

      5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography

6.1 Overview

      6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

6.2 North America

      6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.3 Europe

      6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.5 Rest of the World (RoW) 

      6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Rigorous research and development initiatives for innovative products

      7.1.2 Investing in emerging economies

7.2 Barriers and Future Assumptions

      7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth

 

Chapter 8 Company Profiles

8.1 Anika Therapeutics, Inc. 

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 Arthrex, Inc. 

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product Portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 Baxter International, Inc. 

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 CONMED Corporation

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

      8.4.5 Recent Developments

8.5 DePuy Synthes, Inc. 

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 Medtronic, Inc. 

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Smith & Nephew plc

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Stryker Corporation

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Zimmer Holdings, Inc. 

      8.9.1 Business Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

List of Figures

 

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation

FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market

FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)

FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)

FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) 

FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) 

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

Considered as an emerging field of medical science that aims at regenerating, replacing, or repairing organs, regenerative medicines are witnessing rising demand from across the world. The U.S. National Institutes of Health defines regenerative medicine as the process of creating functional tissues to replace and repair organ or tissue damaged due to congenital defects, age, or disease. Regenerative medicines boast wide-ranging applications in neurology, cardiovascular, musculoskeletal, and orthopedic diseases and ailments.

The report studies the global regenerative medicine market from ground-up covering the market definition, segmentation on the basis of various parameters, and factors influencing its growth trajectory. To present a granular analysis, the global regenerative medicine market is segmented on the basis of technology, by application, and regionally.

The market study enumerates the various advancements impacting the regenerative medicine market, and incorporates in-depth study on its competitive landscape by profiling the prominent enterprises. To present valuable insights pertaining to the market’s growth metrics, the report includes Porter’s five forces analysis, market attractiveness analysis, and key players’ analysis. 

Overview of Global Regenerative Medicine Market

The latest technologies introduced in tissue engineering and stem cell therapy are anticipated to give a significant impetus to the global regenerative medicine (bone and joint) market. In addition, the rising incidence of joint disorders and bone injuries has also considerably aided the expansion of the global market for regenerative medicine. However, the market faces challenges from stringent regulatory compliance, risk of post implantation rejection, and ethical issues related to stem cell therapy. Nevertheless, the global regenerative medicine market, which in 2012 stood at US$2.59 bn, will reach US$6.47 bn by the end of 2019, exhibiting a CAGR of 12.8% between 2012 and 2019.

Based on technology, the market is segmented into stem cell therapy, tissue, engineering, and biomaterials. In terms of application the global regenerative medicine market is segmented into bone graft substitute, autogenic bones, allogeneic bones, osteoarticular diseases, and others.

Regionally, the market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Of these, North America accounted for the largest share in the global regenerative medicine market in 2012 due to the escalating demand for bone and joint reconstructive surgeries. Favorable government initiatives in the region have also supported the growth of the regenerative medicine market in North America. Europe emerged as the second largest regional market for regenerative medicine in 2012. Asia Pacific also exhibits impressive growth prospects for the regenerative medicine market. The region is likely to exhibit the highest CAGR between 2013 and 2019.

Companies mentioned in the research report

The most prominent companies profiled in the report are Anika Therapeutics, Inc., CONMED Corporation, Arthrex, Inc., DePuy Synthes, Inc., Baxter International, Inc., Medtronic, Inc., Stryker Corporation, Smith & Nephew PLC, and Zimmer Holdings, Inc. These enterprises are studied based on aspects such as company overview, business strategies, financial overview, recent developments, and product portfolio.

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others

Regenerative Medicine (Bone and Joint) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

 Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments